Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...

Signet Therapeutics ("Signet"), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, today announced that the first patient has been dosed in the ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

Did you know your liver has a built-in defense system designed to stop cancer before it starts? Scientists at the University of California San Diego School of Medicine have uncovered how this ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer. Metastasis may also be simply referred to as cancer spread. If you have ...

A YOUNG woman has been declared cancer-free after undergoing Britain’s first liver transplant for advanced bowel cancer. Bianca Perea, a 32-year-old trainee lawyer from Manchester, was given the ...

"Going from fatty liver disease to MASH to liver cancer is a very common scenario, and the consequences can be deadly," said Michael Karin, Ph.D., Distinguished Professor in the Department of ...

Scientists have revealed new insights into the origin of liver cancer and, more broadly, on the effects of a high-fat diet on our DNA. Scientists at University of California San Diego School of ...

Photo credit: UC San Diego Health Sciences Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently ...

The incidence of the most common form of liver cancer, hepatocellular carcinoma (HCC), has grown by 25-30% in the past two decades, with much of the growth attributed to the dramatic rise in fatty ...

However, prolonged metabolic stress allows once-senescent liver cells to start dividing and progress to cancer. A MASH-inducing diet caused DNA damage in the liver cells (hepatocytes) of MUP-uPA mice.